Form 4: Hyperfine Director Dan Wolterman Acquires 79,200 Stock Options
SEC Form 4 Filing
Director Dan Wolterman acquired 79,200 stock options in Hyperfine, Inc. on June 12, 2024.
Summary
- On June 12, 2024, Dan Wolterman, a director of Hyperfine, Inc., acquired 79,200 stock options.
- The exercise price of these options is $0.87.
- The options vest on the date of the Issuer's next regular annual stockholders meeting, contingent upon Mr. Wolterman's continued service.
- The options expire on June 12, 2034.
- Following the transaction, Mr. Wolterman directly owns 79,200 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of stock option acquisition by a director. While insider ownership can be a positive signal, this is a routine grant.
Positives
- The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The vesting of the options is contingent upon Mr. Wolterman's continued service, aligning his interests with the company's long-term success.
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment, as it indicates confidence from a company director.
Key Dates
| Date | Description |
|---|---|
| 06/12/2024 | Date of the transaction: Dan Wolterman acquired 79,200 stock options. |
| 06/12/2024 | Date of signature of the form. |
| 06/12/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.